Hospital patterns of use of positive inotropic agents in patients with heart failure

Journal of the American College of Cardiology

Volumn 60, Issue 15, 2012, Pages 1402-1409

  Partovian, Chohreh ^a,b   Gleim, Scott R ^a   Mody, Purav S ^a,b   Li, Shu Xia ^b   Wang, Haiyan ^b   Strait, Kelly M ^b   Allen, Larry A ^c   Lagu, Tara ^d,g   Normand, Sharon Lise T ^e   Krumholz, Harlan M ^a,b,f  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d BAYSTATE MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f YALE UNIVERSITY   (United States)

^g TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

heart failure; in hospital mortality; inotrope use; variation in care

Indexed keywords

DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; MILRINONE;

AGED; ARTICLE; ARTIFICIAL VENTILATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CATHETERIZATION; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INSTITUTIONALIZATION; INTERHOSPITAL COOPERATION; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; RENAL REPLACEMENT THERAPY;

CARDIOTONIC AGENTS; CROSS-SECTIONAL STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALS; HUMANS; LENGTH OF STAY; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES;

EID: 84867076727     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.07.011     Document Type: Article

References (21)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. H. Bueno, J.S. Ross, Y. Wang Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006 JAMA 303 2010 2141 2147
3. S.M. Bernheim, J.N. Grady, Z. Lin National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure Update on publicly reported outcomes measures based on the 2010 release Circ Cardiovasc Qual Outcomes 3 2010 459 467
4. H.M. Krumholz, Y. Wang, J.A. Mattera An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure Circulation 113 2006 1693 1701
5. D. De Backer, P. Biston, J. Devriendt Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 362 2010 779 789
6. M.S. Cuffe, R.M. Califf, K.F. Adams Jr Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1547
7. J.N. Cohn, S.O. Goldstein, B.H. Greenberg Vesnarinone Trial Investigators A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure N Engl J Med 339 1998 1810 1816
8. J.F. Moran, N. Rad, P.J. Scanlon Long term survival of class IV heart failure patients treated with oral amrinone J Clin Pharmacol 29 1989 494 499
9. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
10. J. Lindenfeld, N.M. Albert, J.P. Boehmer HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 2010 e1 e194
11. K. Dickstein, A. Cohen-Solal, G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
12. A. Elixhauser, C. Steiner, D.R. Harris Comorbidity measures for use with administrative data Med Care 36 1998 8 27
13. C.L. Christiansen, C.N. Morris Improving the statistical approach to health care provider profiling Ann Intern Med 127 1997 764 768
14. R. Moineddin, F.I. Matheson, R.H. Glazier A simulation study of sample size for multilevel logistic regression models BMC Med Res Methodol 7 2007 34
15. R.R. Team A Language and Environment for Statistical Computing 2010 R Foundation for Statistical Computing Vienna, Austria
16. K.F. Adams, T. DeMarco, R. Berkowitz Inotrope use and negative outcomes in treatment of acute heart failure in patients with preserved systolic function: data from the ADHERE database (abstr) Circulation 108 Suppl IV 2003 695
17. C.M. O'Connor, W.A. Gattis, B.F. Uretsky Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST) Am Heart J 138 1999 78 86
18. K.F. Adams Jr, G.C. Fonarow, C.L. Emerman Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216
19. W.T. Abraham, K.F. Adams, G.C. Fonarow In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Am Coll Cardiol 46 2005 57 64
20. C.W. Yancy, M. Lopatin, L.W. Stevenson Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database J Am Coll Cardiol 47 2006 76 84
21. U. Elkayam, G. Tasissa, C. Binanay Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure Am Heart J 153 2007 98 104